Classical computational approaches are steadily improving in their ability to predict molecular properties based on their sequences or structure, which is essential in drug discovery, irrespective of its many challenges. The major challenge is to use computational approaches to identify the properties, such as toxicity, solubility, etc. (ADMET), of the drug targets without costing much time. Machine learning and deep learning methods are employed for predicting ADMET properties. The proposed approach combines quantum computing with machine learning for the binary task of toxicity prediction based on the SMILES data. This Quantum Machine Learning (QML) approach involves a novel five-step procedure that converts SMILES to their respective molecular fingerprints, which are in turn dimensionally reduced, consequently forming four qubits. These qubits are inputs to the QML models, such as the Quantum SVC (QSVC), Variational Quantum Circuits (VQC), and Quantum AutoEncoders (QAE). The models are trained and optimized by using different optimizers and then evaluated based on the accuracy metric. The QAE model outperformed the remaining model by achieving an accuracy of 99%.
Classical computational approaches are steadily improving in their ability to predict molecular properties based on their sequences or structure, which is essential in drug discovery, irrespective of its many challenges. The major challenge is to use computational approaches to identify the properties, such as toxicity, solubility, etc. (ADMET), of the drug targets without costing much time. Machine learning and deep learning methods are employed for predicting ADMET properties. The proposed approach combines quantum computing with machine learning for the binary task of toxicity prediction based on the SMILES data. This Quantum Machine Learning (QML) approach involves a novel five-step procedure that converts SMILES to their respective molecular fingerprints, which are in turn dimensionally reduced, consequently forming four qubits. These qubits are inputs to the QML models, such as the Quantum SVC (QSVC), Variational Quantum Circuits (VQC), and Quantum AutoEncoders (QAE). The models are trained and optimized by using different optimizers and then evaluated based on the accuracy metric. The QAE model outperformed the remaining model by achieving an accuracy of 99%.
In the drug discovery paradigm, the evaluation of absorption, distribution, metabolism, and excretion (ADME) and toxicity properties of new chemical entities is one of the most critical issues, which is a time-consuming process, immensely expensive, and poses formidable challenges in pharmaceutical R&D. In recent years, emerging technologies like artificial intelligence (AI), big data, and cloud technologies have garnered great attention to predict the ADME and toxicity of molecules. Currently, the blend of quantum computation and machine learning has attracted considerable attention in almost every field ranging from chemistry to biomedicine and several engineering disciplines as well. Quantum computers have the potential to bring advances in high-throughput experimental techniques and in screening billions of molecules by reducing development costs and time associated with the drug discovery process. Motivated by the efficiency of quantum kernel methods, we proposed a quantum machine learning (QML) framework consisting of a classical support vector classifier algorithm with a kernel-based quantum classifier. To demonstrate the feasibility of the proposed QML framework, the simplified molecular input line entry system (SMILES) notation-based string kernel, combined with a quantum support vector classifier, is used for the evaluation of chemical/drug ADME-Tox properties. The proposed quantum machine learning framework is validated and assessed via large-scale simulations. Based on our results from numerical simulations, the quantum model achieved the best performance as compared to classical counterparts in terms of the area under the curve of the receiver operating characteristic curve (AUC ROC; 0.80-0.95) for predicting outcomes on ADME-Tox data sets for small molecules, with a different number of features. The deployment of the proposed framework in the pharmaceutical industry would be extremely valuable in making the best decisions possible.
Quantum machine learning (QML) has been demonstrated to have great potential in revolutionizing the process of drug discovery by dealing with the problem of high computational complexity of molecular simulations. Conventional computational techniques are not very effective in predicting the properties of molecules and pharmaceutical activity because the simulation of large molecules is too complex. This paper will discuss how QML algorithms can be used, specifically variational quantum circuits and quantum kernel methods, to improve the predictability of molecular properties and accelerate the process of drug discovery. To enhance the prediction accuracy, the research use quantum-enhanced feature extraction together with classical machine learning technologies. Research methodology is applied to datasets of molecular structure and biological activity in order to provide a more useful model to learn about how molecular features relate to biological outcomes using quantum machine learning models. These results suggest that it is 15 % more accurate in prediction and 20 % faster in computing high-dimensional molecular simulations compared to standard machine learning algorithms. The efficiency of the QML-based method is statistically proven with an accuracy 89%, precision 87%, and an F1-score of 0.91. The results point to the possible ability of QML to decrease the time and computational resources spent on the exploration of drug discovery, providing a new direction for the improvement of molecular property prediction. The study is a contribution to the emerging area of QML in pharmaceutical use and demonstrates that it can simplify drug discovery and enhance the accuracy with which predictions are made. The paper demonstrates that QML may produce a significant impact on the drug development process by simulating the molecular properties faster, more effectively, and more accurately.
The recent pandemic outbreak has posed significant challenges for medical research, particularly in drug discovery. Machine learning (ML) has become increasingly prevalent in various stages of drug discovery, aiming to support the advancement of new drug research while reducing time and cost investments. Furthermore, the emergence of quantum computing and quantum machine learning (QML) represents a significant advancement in this field, offering the ability to tackle the complex processes involved in drug discovery. This review provides a comprehensive perspective, comparing advanced QML to classical ML in drug discovery applications including drug design, virtual screening, and absorption, distribution, metabolism, excretion and toxicity (ADMET) prediction. Additionally, we summarize the current applications of QML algorithms to real-world datasets utilized in clinical research and drug discovery.
This paper explores the potential of quantum machine learning (QML) in revolutionizing drug molecule design. Traditional drug discovery is a time-consuming and expensive process, often hampered by the limitations of classical computational methods in accurately simulating molecular interactions. Quantum computing, with its inherent ability to model quantum phenomena, offers a promising avenue for overcoming these challenges. This work investigates the application of QML algorithms to predict molecular properties, simulate drug-target interactions, and ultimately guide the design of novel drug molecules. Specifically, we outline a framework leveraging quantum algorithms for variational quantum eigensolver (VQE) and quantum approximate optimization algorithm (QAOA) to tackle the complexities of molecular simulations. The core claim is that QML can accelerate the drug development pipeline by providing more accurate and efficient predictions. The mechanism relies on the ability of QML models to capture the subtle quantum effects governing molecular interactions, leading to improved predictions of binding affinities, ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) properties, and overall drug efficacy. This paper lays the groundwork for future research in this emerging field, highlighting the potential for QML to significantly reshape the landscape of pharmaceutical research and development.
Quantum Machine Learning (QML) offers a transformative approach to drug design and optimization, addressing longstanding challenges in identifying novel drug candidates and refining existing ones. This paper explores the potential of QML to accelerate the drug discovery process by leveraging quantum algorithms for molecular structure exploration and optimization. We present a novel framework incorporating quantum simulation and machine learning, demonstrating its efficacy in predicting drug-target interactions and optimizing molecular properties. The core mechanism centers around accelerating the identification of promising compounds through enhanced molecular search and optimization, while quantum computational modeling provides unprecedented precision. The integration of quantum machine learning with traditional drug design methods promises to significantly reduce development time and costs, ultimately impacting the pharmaceutical industry.
Quantitative Structure-Activity Relationship (QSAR) modeling is a cornerstone of computational drug discovery. This research demonstrates the successful application of a Quantum Multiple Kernel Learning (QMKL) framework to enhance QSAR classification, showing a notable performance improvement over classical methods. We apply this methodology to a dataset for identifying DYRK1A kinase inhibitors. The workflow involves converting SMILES representations into numerical molecular descriptors, reducing dimensionality via Principal Component Analysis (PCA), and employing a Support Vector Machine (SVM) trained on an optimized combination of multiple quantum and classical kernels. By benchmarking the QMKL-SVM against a classical Gradient Boosting model, we show that the quantum-enhanced approach achieves a superior AUC score, highlighting its potential to provide a quantum advantage in challenging cheminformatics classification tasks.